Ensign Group (ENSG) | Financial Analysis & Statements
Ensign Group, Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.4B
Gross Profit
222.3M
16.34%
Operating Income
123.8M
9.10%
Net Income
95.5M
7.02%
EPS (Diluted)
$1.61
Balance Sheet Metrics
Total Assets
5.5B
Total Liabilities
3.2B
Shareholders Equity
2.2B
Debt to Equity
1.44
Cash Flow Metrics
Operating Cash Flow
75.6M
Free Cash Flow
373.8M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Ensign Group Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.1B | 4.3B | 3.7B | 3.0B | 2.6B |
| Cost of Goods Sold | 4.3B | 3.6B | 3.1B | 2.5B | 2.2B |
| Gross Profit | 799.5M | 667.6M | 590.8M | 518.0M | 468.2M |
| Gross Margin % | 15.8% | 15.7% | 15.8% | 17.1% | 17.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 269.8M | 225.1M | 263.0M | 158.8M | 151.8M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 269.8M | 225.1M | 263.0M | 158.8M | 151.8M |
| Operating Income | 425.3M | 358.3M | 255.4M | 296.8M | 260.5M |
| Operating Margin % | 8.4% | 8.4% | 6.8% | 9.8% | 9.9% |
| Non-Operating Items | |||||
| Interest Income | 24.5M | 28.7M | - | - | 4.4M |
| Interest Expense | 8.0M | 8.3M | 8.1M | 8.9M | 6.8M |
| Other Non-Operating Income | 13.8M | 7.3M | 25.5M | 1.2M | 4.4M |
| Pre-tax Income | 455.6M | 386.1M | 272.8M | 289.1M | 258.0M |
| Income Tax | 111.4M | 87.6M | 62.9M | 64.4M | 60.3M |
| Effective Tax Rate % | 24.4% | 22.7% | 23.1% | 22.3% | 23.4% |
| Net Income | 344.3M | 298.5M | 209.8M | 224.7M | 197.7M |
| Net Margin % | 6.8% | 7.0% | 5.6% | 7.4% | 7.5% |
| Key Metrics | |||||
| EBITDA | 567.9M | 478.5M | 353.2M | 360.4M | 320.8M |
| EPS (Basic) | - | $5.26 | $3.76 | $4.09 | $3.57 |
| EPS (Diluted) | - | $5.12 | $3.65 | $3.95 | $3.42 |
| Basic Shares Outstanding | - | 56655000 | 55708000 | 54887000 | 54486000 |
| Diluted Shares Outstanding | - | 56655000 | 55708000 | 54887000 | 54486000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Ensign Group Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 503.9M | 464.6M | 509.6M | 316.3M | 262.2M |
| Short-term Investments | 68.5M | 62.3M | 17.2M | 15.4M | 13.8M |
| Accounts Receivable | 637.0M | 569.9M | 485.0M | 408.4M | 328.7M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 62.9M | 60.9M | 35.0M | 41.0M | 29.6M |
| Total Current Assets | 1.3B | 1.2B | 1.0B | 781.1M | 639.7M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.6B | 2.3B | 2.1B | 1.7B | 1.4B |
| Goodwill | 202.3M | 203.3M | 160.3M | 160.2M | 127.3M |
| Intangible Assets | 6.4M | 7.3M | 6.5M | 6.4M | 6.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 124.7M | 112.8M | 104.7M | 74.4M | 60.1M |
| Total Non-Current Assets | 4.2B | 3.5B | 3.1B | 2.7B | 2.2B |
| Total Assets | 5.5B | 4.7B | 4.2B | 3.5B | 2.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 97.3M | 98.9M | 92.8M | 77.1M | 58.1M |
| Short-term Debt | 119.0M | 97.6M | 86.5M | 69.7M | 55.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 894.3M | 743.4M | 734.7M | 582.1M | 523.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.1B | 1.9B | 1.8B | 1.5B | 1.2B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 82.3M | 64.2M | 49.4M | 33.3M | 27.1M |
| Total Non-Current Liabilities | 2.3B | 2.1B | 1.9B | 1.6B | 1.3B |
| Total Liabilities | 3.2B | 2.8B | 2.7B | 2.2B | 1.8B |
| Equity | |||||
| Common Stock | 62.0K | 61.0K | 60.0K | 59.0K | 58.0K |
| Retained Earnings | 1.8B | 1.4B | 1.1B | 946.3M | 734.0M |
| Treasury Stock | 139.2M | 117.8M | 116.6M | 114.6M | 83.0M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.2B | 1.8B | 1.5B | 1.2B | 1.0B |
| Key Metrics | |||||
| Total Debt | 2.2B | 2.0B | 1.9B | 1.6B | 1.3B |
| Working Capital | 378.0M | 414.2M | 312.2M | 199.1M | 116.6M |
Balance Sheet Composition
Ensign Group Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 344.3M | 298.5M | 209.8M | 224.7M | 197.7M |
| Depreciation & Amortization | 104.3M | 84.1M | 72.4M | 62.4M | 56.0M |
| Stock-Based Compensation | 48.3M | 36.2M | 30.8M | 22.7M | 18.7M |
| Working Capital Changes | -76.6M | -80.2M | -70.5M | -88.4M | -53.6M |
| Operating Cash Flow | 409.7M | 338.1M | 265.0M | 222.1M | 220.8M |
| Investing Activities | |||||
| Capital Expenditures | -193.6M | -158.2M | -106.2M | -87.5M | -69.6M |
| Acquisitions | -323.3M | -156.5M | 0 | -16.4M | -8.0M |
| Investment Purchases | -110.7M | -105.1M | -29.6M | -22.0M | -32.3M |
| Investment Sales | 99.7M | 26.4M | 18.9M | 14.4M | 27.5M |
| Investing Cash Flow | -513.2M | -390.1M | -182.7M | -186.2M | -173.8M |
| Financing Activities | |||||
| Share Repurchases | -21.4M | -1.2M | -1.9M | -31.6M | -11.8M |
| Dividends Paid | -14.4M | -13.7M | -12.9M | -12.2M | -11.5M |
| Debt Issuance | 0 | 400.0K | 150.0K | 411.0K | 45.2M |
| Debt Repayment | -4.1M | -4.4M | -4.0M | -4.1M | -3.1M |
| Financing Cash Flow | -40.9M | -24.4M | -19.0M | -44.9M | -43.2M |
| Free Cash Flow | 370.7M | 188.9M | 270.5M | 185.0M | 206.0M |
| Net Change in Cash | -144.3M | -76.4M | 63.3M | -9.0M | 3.9M |
Cash Flow Trend
Ensign Group Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
32.78
Forward P/E
23.27
Price to Book
4.95
Price to Sales
2.21
PEG Ratio
1.76
Profitability Ratios
Profit Margin
6.80%
Operating Margin
9.10%
Return on Equity
16.90%
Return on Assets
5.25%
Financial Health
Current Ratio
1.42
Debt to Equity
98.70
Beta
0.82
Per Share Data
EPS (TTM)
$5.85
Book Value per Share
$38.71
Revenue per Share
$88.26
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ENSG | 11.1B | 32.78 | 4.95 | 16.90% | 6.80% | 98.70 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Universal Health | 11.1B | 7.84 | 1.52 | 21.33% | 8.57% | 69.73 |
| Encompass Health | 10.2B | 18.52 | 4.21 | 24.82% | 9.54% | 82.85 |
| DaVita | 10.0B | 16.32 | 9.13 | 64.85% | 5.47% | 1,111.35 |
Financial data is updated regularly. All figures are in the company's reporting currency.






